Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

Dastani, Zari and Hivert, Marie-France and Timpson, Nicholas and Perry, John R. B. and Yuan, Xin and Scott, Robert A. and Henneman, Peter and Heid, Iris M. and Kizer, Jorge R. and Lyytikainen, Leo-Pekka and Fuchsberger, Christian and Tanaka, Toshiko and Morris, Andrew P. and Small, Kerrin and Isaacs, Aaron and Beekman, Marian and Coassin, Stefan and Lohman, Kurt and Qi, Lu and Kanoni, Stavroula and Pankow, James S. and Uh, Hae-Won and Wu, Ying and Bidulescu, Aurelian and Rasmussen-Torvik, Laura J. and Greenwood, Celia M. T. and Ladouceur, Martin and Grimsby, Jonna and Manning, Alisa K. and Liu, Ching-Ti and Kooner, Jaspal and Mooser, Vincent E. and Vollenweider, Peter and Kapur, Karen A. and Chambers, John and Wareham, Nicholas J. and Langenberg, Claudia and Frants, Rune and Willems-vanDijk, Ko and Oostra, Ben A. and Willems, Sara M. and Lamina, Claudia and Winkler, Thomas W. and Psaty, Bruce M. and Tracy, Russell P. and Brody, Jennifer and Chen, Ida and Viikari, Jorma and Kahonen, Mika and Pramstaller, Peter P. and Evans, David M. and St Pourcain, Beate and Sattar, Naveed and Wood, Andrew R. and Bandinelli, Stefania and Carlson, Olga D. and Egan, Josephine M. and Bohringer, Stefan and van Heemst, Diana and Kedenko, Lyudmyla and Kristiansson, Kati and Nuotio, Marja-Liisa and Loo, Britt-Marie and Harris, Tamara and Garcia, Melissa and Kanaya, Alka and Haun, Margot and Klopp, Norman and Wichmann, H. -Erich and Deloukas, Panos and Katsareli, Efi and Couper, David J. and Duncan, Bruce B. and Kloppenburg, Margreet and Adair, Linda S. and Borja, Judith B. and Wilson, James G. and Musani, Solomon and Guo, Xiuqing and Johnson, Toby and Semple, Robert and Teslovich, Tanya M. and Allison, Matthew A. and Redline, Susan and Buxbaum, Sarah G. and Mohlke, Karen L. and Meulenbelt, Ingrid and Ballantyne, Christie M. and Dedoussis, George V. and Hu, Frank B. and Liu, Yongmei and Paulweber, Bernhard and Spector, Timothy D. and Slagboom, P. Eline and Ferrucci, Luigi and Jula, Antti and Perola, Markus and Raitakari, Olli and Florez, Jose C. and Salomaa, Veikko and Eriksson, Johan G. and Frayling, Timothy M. and Hicks, Andrew A. and Lehtimaki, Terho and Smith, George Davey and Siscovick, David S. and Kronenberg, Florian and van Duijn, Cornelia and Loos, Ruth J. F. and Waterworth, Dawn M. and Meigs, James B. and Dupuis, Josee and Richards, J. Brent (2012) Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals. PLOS GENETICS, 8 (3): e1002607. ISSN 1553-7404,

Full text not available from this repository. (Request a copy)

Abstract

Circulating levels of adiponectin, a hormone produced predominantly by adipocytes, are highly heritable and are inversely associated with type 2 diabetes mellitus (T2D) and other metabolic traits. We conducted a meta-analysis of genome-wide association studies in 39,883 individuals of European ancestry to identify genes associated with metabolic disease. We identified 8 novel loci associated with adiponectin levels and confirmed 2 previously reported loci (P=4.5 x 10(-8)-1.2 x 10(-43)). Using a novel method to combine data across ethnicities (N = 4,232 African Americans, N = 1,776 Asians, and N = 29,347 Europeans), we identified two additional novel loci. Expression analyses of 436 human adipocyte samples revealed that mRNA levels of 18 genes at candidate regions were associated with adiponectin concentrations after accounting for multiple testing (p<3 x 10(-4)). We next developed a multi-SNP genotypic risk score to test the association of adiponectin decreasing risk alleles on metabolic traits and diseases using consortia-level meta-analytic data. This risk score was associated with increased risk of T2D (p=4.3 x 10(-3), n = 22,044), increased triglycerides (p=2.6 x 10(-14), n = 93,440), increased waist-to-hip ratio (p=1.8 x 10(-5), n = 77,167), increased glucose two hours post oral glucose tolerance testing (p=4.4 x 10(-3), n = 15,234), increased fasting insulin (p = 0.015, n = 48,238), but with lower in HDL-cholesterol concentrations (p=4.5x10(-13), n = 96,748) and decreased BMI (p= 1.4 x 10(-14), n = 121,335). These findings identify novel genetic determinants of adiponectin levels, which, taken together, influence risk of T2D and markers of insulin resistance.

Item Type: Article
Uncontrolled Keywords: GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; LIPID CONCENTRATIONS; ADIPOSE-TISSUE; GENETIC-BASIS; RISK; POPULATION; RECEPTOR; VARIANTS;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Institut für Epidemiologie und Präventivmedizin
Depositing User: Dr. Gernot Deinzer
Date Deposited: 19 May 2020 07:02
Last Modified: 19 May 2020 07:02
URI: https://pred.uni-regensburg.de/id/eprint/19206

Actions (login required)

View Item View Item